Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Applications for changes in the OPCS-4.11 classification in England accepted till December 1, 2024

In September 2023, NHS England defined the roadmap and key dates for the next version of the OPCS-4 nomenclature of procedures, which is updated every three years. 

The release of OPCS-4.11 is scheduled for April 1, 2026. The applications for changes can be submitted via the Request Submission Portal no later than December 1, 2024, to be implemented in the OPCS-4.11 version. 

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.